new_0222_0484|FHTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0484|FHTX|1|Foghorn Therapeutics Inc Total Current Assets (Quarterly) (USD)|Foghorn Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Foghorn Therapeutics Inc Inventories (Quarterly) (USD)|Foghorn Therapeutics Inc Net PP&E (Quarterly) (USD)|Foghorn Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Foghorn Therapeutics Inc Total Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Deposits (Quarterly) (USD)|Foghorn Therapeutics Inc Book Value (Quarterly) (USD)|Foghorn Therapeutics Inc Retained Earnings (Quarterly) (USD)|Foghorn Therapeutics Inc Treasury Stock (Quarterly) (USD)|Foghorn Therapeutics Inc EV to Revenues|Foghorn Therapeutics Inc EV to Earnings|Foghorn Therapeutics Inc EV to Free Cash Flow|Foghorn Therapeutics Inc EV to Assets (Quarterly)|Foghorn Therapeutics Inc PS Ratio|Foghorn Therapeutics Inc PE Ratio|Foghorn Therapeutics Inc Price to Book Value|Foghorn Therapeutics Inc PEG Ratio|Foghorn Therapeutics Inc Debt to Equity Ratio|Foghorn Therapeutics Inc Dividend Yield|Foghorn Therapeutics Inc Shareholder Yield (TTM)|Foghorn Therapeutics Inc Percent of Shares Outstanding Short|Foghorn Therapeutics Inc Total Receivables (Quarterly) (USD)|Foghorn Therapeutics Inc Total Payables (Quarterly) (USD)|Foghorn Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Foghorn Therapeutics Inc Return on Invested Capital|Foghorn Therapeutics Inc Quality Ratio Score|Foghorn Therapeutics Inc Momentum Score|Foghorn Therapeutics Inc Beta (1Y)|Foghorn Therapeutics Inc Sustainable Growth Rate (TTM)|Foghorn Therapeutics Inc Institutional Investor Ownership Percentage|Foghorn Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Foghorn Therapeutics Inc Total Employees (Annual)|Foghorn Therapeutics Inc EPS Diluted (Quarterly) (USD)|Foghorn Therapeutics Inc Shares Outstanding|Foghorn Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Foghorn Therapeutics Inc Ordinary Shares Number (Quarterly)|Foghorn Therapeutics Inc Payout Ratio|Foghorn Therapeutics Inc Quick Ratio (Quarterly)|Foghorn Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Foghorn Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Foghorn Therapeutics Inc Effective Tax Rate (TTM)|Foghorn Therapeutics Inc Return on Equity|Foghorn Therapeutics Inc Net Income (TTM) (USD)|Foghorn Therapeutics Inc Revenue (TTM) (USD)|Foghorn Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Foghorn Therapeutics Inc Revenue (Quarterly) (USD)|Foghorn Therapeutics Inc Gross Profit (Quarterly) (USD)|Foghorn Therapeutics Inc SG&A Expense (Quarterly) (USD)|Foghorn Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Foghorn Therapeutics Inc Net Income (Quarterly) (USD)|Foghorn Therapeutics Inc Net Interest Income (Quarterly) (USD)|Foghorn Therapeutics Inc Price (USD)|Foghorn Therapeutics Inc Total Return Price (USD)|Foghorn Therapeutics Inc Enterprise Value (USD)|Foghorn Therapeutics Inc 30-Day Average Daily Volume|Foghorn Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0484|FHTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0484|FHTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0484|FHTX|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||1.44099378882|92|1.44912280702|91|1.43827160494||1.44755244755||91.25|1.45180722892||15.2666666667||106.5|106.5|92||31|30.6666666667|92|30.5|91.375|122|91.375|31.25||106.5|92|91.25|91.375|||92|91.4|92||91.25||91.375|91.375|91.375|91.375|1.45045045045|1.45045045045|1.45180722892|1.45214521452|1.4375||
new_0222_0484|FHTX|6|6|6||6||6|6|6||6|6||161|1|285|3|162||286||4|332||30||6|6|1||2|3|1|14|8|1|8|12||6|1|4|8|||1|5|1||4||8|8|8|8|333|333|332|303|80||
new_0222_0484|FHTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0484|FHTX|201909||||||||||||||||||||||||||||||||||22.1274||-0.5917||||||-0.5917|||||||||1.808|-13.092|-13.092|0.008|||||||
new_0222_0484|FHTX|201912|16.885|14.981||3.713||110.358|12.652|97.706||-88.016|-94.136|||||||||||||||3.439||||||||22.1274||-0.6911|||35.6948|||-0.6911|||||||||1.666|-15.292|-15.292|-0.107|||||||
new_0222_0484|FHTX|202003||||||||||||||||||||||||||||||||||22.1274||-0.6305||||||-0.6306|||||||||2.221|-13.952|-13.952|-0.229|||||||
new_0222_0484|FHTX|202006|38.967|36.563||53.537||76.201|15.865|60.336||18.113|-123.811|||||||||||||||2.981|0.002|||||||22.1274|85|-0.7106|||35.6948|||-0.7106||||-58.059|||||1.911|-15.723|-15.723|-0.184|||||||
new_0222_0484|FHTX|202009|77.764|74.62||60.75||275.751|21.301|254.45||-133.323|-142.178||||||||||-0.1109|||0.0515||3.554|0.001||||||4.3473|35.6948||-0.5146|35.8136||35.6948||3.5031|-0.5126||||-63.334|||0.179||2.555|-18.367|-18.367|0.192|15.98|15.98|510.5739|||20.2|
new_0222_0484|FHTX|202012|190.687|185.77||62.332||109.407|18.846|90.561||146.187|-162.936||||-12.2108|2.2678|||5.1014||0.1344|||0.9083||3.68|0.004||||||76.9292|36.7909|95|-0.5642|36.7909||36.7909||9.8573|-0.5582||||-68.8|||0.251||4.559|-20.758|-20.758|0.243|20.27|20.27|579.6355|167452.9667||16.5|16.46
new_0222_0484|FHTX|202103|165.315|160.917||61.235||104.722|16.332|88.39||125.164|-185.922||||-5.6773|1.4973|||3.8779||0.1577|||2.0143||2.911|0.004||||||76.9532|36.8173||-0.62|36.8268||36.8268||9.8529|-0.62||||-77.834|||0.286||4.69|-22.986|-22.986|0.144|13.18|13.18|344.1992|103359.7||10.98|10.41
new_0222_0484|FHTX|202106|144.672|141.273||59.676||104.336|16.414|87.922||104.19|-209.033||273.2303|-3.1901|-4.1521|1.3037|391.8154||3.7749||0.1903|||2.6141||3.406|0.004|-107.7982||||-163.6801|89.4452|36.8474||-0.63|36.8614||36.8614||8.6069|-0.63|||-163.6801|-85.222|0.995||0.279||4.898|-23.111|-23.111|0.15|10.67|10.67|271.8641|170381.3667||9.07|12.98
new_0222_0484|FHTX|202109|123.953|120.842||57.952||105.087|19.296|85.791||80.982|-235.113||484.3711|-4.4666|-4.9708|2.2309|599.0852||6.3722||0.2459|||2.3298||3.821|0.004|-111.3997||2|0.8837|-143.7732|85.3872|36.9718||-0.71|37.0448||37.0448||6.2625|-0.71|||-143.7732|-92.935|0.857||0.041||5.808|-26.08|-26.08|0.181|13.93|13.93|415.1061|90355.0667|-20.6875|12.69|11.57
new_0222_0484|FHTX|202112|||||||||||||872.0617||-8.9494||983.5663||10.475|||||2.5333||||||2|1.454||77.9686||||||||||||||||||||||22.87|22.87|747.3569|1063037.0333|12.8268|15.38|10.42